Notes - Segment Information, Etc.

TOWA PHARMACEUTICAL CO.,LTD. - Filing #7316972

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
227,934,000,000 JPY
178,715,000,000 JPY
49,218,000,000 JPY
227,934,000,000 JPY
JPY
155,538,000,000 JPY
53,321,000,000 JPY
208,859,000,000 JPY
JPY
208,859,000,000 JPY
Transactions with other segments
105,000,000 JPY
JPY
105,000,000 JPY
JPY
-105,000,000 JPY
JPY
166,000,000 JPY
166,000,000 JPY
-166,000,000 JPY
JPY
Other items
Depreciation
13,659,000,000 JPY
11,601,000,000 JPY
2,058,000,000 JPY
13,659,000,000 JPY
JPY
12,160,000,000 JPY
2,101,000,000 JPY
14,261,000,000 JPY
JPY
14,261,000,000 JPY
Increase in property, plant and equipment and intangible assets
35,967,000,000 JPY
33,748,000,000 JPY
2,218,000,000 JPY
35,967,000,000 JPY
JPY
36,843,000,000 JPY
2,801,000,000 JPY
39,645,000,000 JPY
JPY
39,645,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.